283 related articles for article (PubMed ID: 19624491)
1. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies.
Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK
Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation of pig cells for resistance to human antibody-mediated rejection.
Hara H; Long C; Lin YJ; Tai HC; Ezzelarab M; Ayares D; Cooper DK
Transpl Int; 2008 Dec; 21(12):1163-74. PubMed ID: 18764834
[TBL] [Abstract][Full Text] [Related]
3. Investigation of red blood cells from alpha1,3-galactosyltransferase-knockout pigs for human blood transfusion.
Rouhani FJ; Dor FJ; Cooper DK
Transfusion; 2004 Jul; 44(7):1004-12. PubMed ID: 15225240
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered pigs as a source for clinical red blood cell transfusion.
Cooper DK; Hara H; Yazer M
Clin Lab Med; 2010 Jun; 30(2):365-80. PubMed ID: 20513556
[TBL] [Abstract][Full Text] [Related]
5. Initial investigation on the feasibility of porcine red blood cells from genetically modified pigs as an alternative to human red blood cells for transfusion.
Park S; Lee H; Park EM; Roh J; Kang PI; Shim J; Choi K; Kang HJ
Front Immunol; 2023; 14():1298035. PubMed ID: 38035112
[TBL] [Abstract][Full Text] [Related]
6. Initial investigation of the potential of modified porcine erythrocytes for transfusion in primates.
Eckermann JM; Buhler LH; Zhu A; Dor FJ; Awwad M; Cooper DK
Xenotransplantation; 2004 Jan; 11(1):18-26. PubMed ID: 14962289
[TBL] [Abstract][Full Text] [Related]
7. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells.
Ide K; Ohdan H; Kobayashi T; Hara H; Ishiyama K; Asahara T
Xenotransplantation; 2005 May; 12(3):181-8. PubMed ID: 15807768
[TBL] [Abstract][Full Text] [Related]
8. Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses.
Ezzelarab M; Ezzelarab C; Wilhite T; Kumar G; Hara H; Ayares D; Cooper DK
Xenotransplantation; 2011; 18(3):183-95. PubMed ID: 21696448
[TBL] [Abstract][Full Text] [Related]
9. Serum Antibody Binding and Cytotoxicity to Pig Cells in Chinese Subjects: Relevance to Clinical Renal Xenotransplantation.
Li T; Feng H; Du J; Xia Q; Cooper DKC; Jiang H; He S; Pan D; Chen G; Wang Y
Front Immunol; 2022; 13():844632. PubMed ID: 35418974
[TBL] [Abstract][Full Text] [Related]
10. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
[TBL] [Abstract][Full Text] [Related]
11. Buccal mucosal cell immunohistochemistry: a simple method of determining the ABH phenotype of baboons, monkeys, and pigs.
Busch J; Specht S; Ezzelarab M; Cooper DK
Xenotransplantation; 2006 Jan; 13(1):63-8. PubMed ID: 16497213
[TBL] [Abstract][Full Text] [Related]
12. Identification of human preformed antibody targets in GTKO pigs.
Burlak C; Wang ZY; Chihara RK; Lutz AJ; Wang Y; Estrada JL; Tector AJ
Xenotransplantation; 2012; 19(2):92-101. PubMed ID: 22497511
[TBL] [Abstract][Full Text] [Related]
13. Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.
Gao B; Long C; Lee W; Zhang Z; Gao X; Landsittel D; Ezzelarab M; Ayares D; Huang Y; Cooper DKC; Wang Y; Hara H
PLoS One; 2017; 12(7):e0180768. PubMed ID: 28715486
[TBL] [Abstract][Full Text] [Related]
14. Anti-pig IgE and IgA Antibodies in Naive Primates and Nonhuman Primates With Pig Xenografts.
Li Q; Iwase H; Yamamoto T; Nguyen HQ; Ayares D; Wang Y; Cooper DKC; Hara H
Transplantation; 2021 Feb; 105(2):318-327. PubMed ID: 32796494
[TBL] [Abstract][Full Text] [Related]
15. Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans.
Hara H; Ezzelarab M; Rood PP; Lin YJ; Busch J; Ibrahim Z; Zhu X; Ball S; Ayares D; Zeevi A; Awwad M; Cooper DK
Xenotransplantation; 2006 Jul; 13(4):357-65. PubMed ID: 16768729
[TBL] [Abstract][Full Text] [Related]
16. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
Baumann BC; Stussi G; Huggel K; Rieben R; Seebach JD
Transplantation; 2007 Jan; 83(2):193-201. PubMed ID: 17264816
[TBL] [Abstract][Full Text] [Related]
18. The sharing of target-epitopes between human anti-ABO hemagglutinating and anti-Pig (xeno) endothelium or anti-Pig thyroglobulin antibodies.
Morita N; Hagihara M; Kanai N; Hiraga S; Saito A; Sakai H; Tsuji K
Tokai J Exp Clin Med; 2003 Jul; 28(2):71-80. PubMed ID: 14714832
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous immunoglobulin (IVIg) on primate complement-dependent cytotoxicity of genetically engineered pig cells: relevance to clinical xenotransplantation.
Yamamoto T; Cui Y; Patel D; Jagdale A; Iwase H; Ayares D; Cooper DKC; Hara H
Sci Rep; 2020 Jul; 10(1):11747. PubMed ID: 32678137
[TBL] [Abstract][Full Text] [Related]
20. Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs.
Hara H; Koike N; Long C; Piluek J; Roh DS; SundarRaj N; Funderburgh JL; Mizuguchi Y; Isse K; Phelps CJ; Ball SF; Ayares DL; Cooper DK
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5278-86. PubMed ID: 21596821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
